Please enable JavaScript to continue using this application.

Compare $CAMP vs $EVMN | Chartloom

Compare

$CAMP vs $EVMN

CAMP4 Therapeutics Corp · Evommune Inc

CAMP

CAMP4 Therapeutics Corp

EVMN

Evommune Inc

Compare $CAMP vs $EVMN

Comparing CAMP4 Therapeutics Corp and Evommune Inc

CAMPCAMP4 Therapeutics Corp

EVMNEvommune Inc

CAMPCAMP4 Therapeutics Corp

Market cap

$196M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

19.59x

Rev growth (TTM)

40.3%

YTD performance

-37.2%

52W performance

6.5%

FCF yield

-14.7%

EVMNEvommune Inc

Market cap

$225M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-63.9%

52W performance

-69.1%

FCF yield

-55.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CAMP

EVMN

Detailed metrics comparison

CAMP

CAMP4 Therapeutics Corp

EVMN

Evommune Inc

Market Cap

CAMP$196M

EVMN$225M

Enterprise Value

CAMP$109M

EVMN$166M

Price

CAMP$3.77

EVMN$6.25

P/E Ratio

CAMPN/A

EVMNN/A

P/S Ratio

CAMP46.44x

EVMN14.07x

EV/Sales

CAMP25.94x

EVMN10.38x

EV/EBITDA

CAMP0.00x

EVMN0.00x

P/B Ratio

CAMP8.12x

EVMN0.90x

P/FCF Ratio

CAMPN/A

EVMNN/A

EV/FCF

CAMP-3.81x

EVMN-1.33x

PEG Ratio

CAMPN/A

EVMNN/A

Forward P/E (NTM)

CAMPN/A

EVMNN/A

Forward P/S (NTM)

CAMP19.59x

EVMNN/A

Revenue (TTM)

CAMP$4M

EVMN$16M

Revenue Growth (YoY)

CAMP40.3%

EVMNN/A

Forward Rev Growth

CAMP-10.8%

EVMN881.5%

Gross Margin (TTM)

CAMP35.8%

EVMN0.0%

Operating Margin (TTM)

CAMP0.0%

EVMN0.0%

EBITDA Margin (TTM)

CAMP-1199.3%

EVMN-1097.9%

Net Margin (TTM)

CAMP-2543.7%

EVMN-943.2%

FCF Margin (TTM)

CAMP-681.2%

EVMN-779.8%

Net Income (TTM)

CAMP$-107M

EVMN$-151M

FCF (TTM)

CAMP$-29M

EVMN$-125M

EPS (TTM)

CAMP-$1.85

EVMN-$4.18

ROE (TTM)

CAMP-19474.0%

EVMN-4676.0%

ROA (TTM)

CAMP-10642.0%

EVMN-4337.0%

ROIC (TTM)

CAMP-19457.0%

EVMN-4661.0%

Cash

CAMP$86M

EVMN$60M

Debt

CAMP$0

EVMN$952K

Net Cash/Debt

CAMP$86M

EVMN$59M

Current Ratio (TTM)

CAMP4.70x

EVMN11.68x

Quick Ratio (TTM)

CAMP4.69x

EVMN11.48x

Debt/Equity (TTM)

CAMP0.00x

EVMN0.00x

Debt/Assets (TTM)

CAMP0.0%

EVMN0.0%

Interest Coverage (TTM)

CAMPN/A

EVMNN/A

Net Debt/EBITDA (TTM)

CAMP0.00x

EVMN0.00x

Beta

CAMP-24.51

EVMN0.62

52W Performance

CAMP6.5%

EVMN-69.1%

YTD Performance

CAMP-37.2%

EVMN-63.9%

% from 52W High

CAMP-51.4%

EVMN-81.2%

% from 52W Low

CAMP31.8%

EVMN3.8%

Asset Turnover (TTM)

CAMP0.79x

EVMN0.00x

FCF Yield (TTM)

CAMP-14.7%

EVMN-55.4%

Earnings Yield (TTM)

CAMP-54.8%

EVMN-67.0%

Dividend Yield (TTM)

CAMPN/A

EVMNN/A

Rule of 40

CAMP-640.9

EVMN-779.8

EV/GP/RG

CAMP0.53

EVMNN/A

Ticker research

View CAMP research View EVMN research

Metric	CAMP CAMP4 Therapeutics Corp	EVMN Evommune Inc
Market & Valuation
Market Cap	$196M	$225M
Enterprise Value	$109M	$166M
Price	$3.77	$6.25
P/E Ratio	N/A	N/A
P/S Ratio	46.44x	14.07x
EV/Sales	25.94x	10.38x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.12x	0.90x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.81x	-1.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	19.59x	N/A
Revenue & Growth
Revenue (TTM)	$4M	$16M
Revenue Growth (YoY)	40.3%	N/A
Forward Rev Growth	-10.8%	881.5%
Profitability
Gross Margin (TTM)	35.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1199.3%	-1097.9%
Net Margin (TTM)	-2543.7%	-943.2%
FCF Margin (TTM)	-681.2%	-779.8%
Net Income (TTM)	$-107M	$-151M
FCF (TTM)	$-29M	$-125M
EPS (TTM)	-$1.85	-$4.18
ROE (TTM)	-19474.0%	-4676.0%
ROA (TTM)	-10642.0%	-4337.0%
ROIC (TTM)	-19457.0%	-4661.0%
Financial Health
Cash	$86M	$60M
Debt	$0	$952K
Net Cash/Debt	$86M	$59M
Current Ratio (TTM)	4.70x	11.68x
Quick Ratio (TTM)	4.69x	11.48x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-24.51	0.62
52W Performance	6.5%	-69.1%
YTD Performance	-37.2%	-63.9%
% from 52W High	-51.4%	-81.2%
% from 52W Low	31.8%	3.8%
Efficiency & Yields
Asset Turnover (TTM)	0.79x	0.00x
FCF Yield (TTM)	-14.7%	-55.4%
Earnings Yield (TTM)	-54.8%	-67.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-640.9	-779.8
EV/GP/RG	0.53	N/A
Ticker research	View CAMP research	View EVMN research

Valuation

P/S Ratio

EVMN

14.07x

CAMP

46.44x

EV/FCF

CAMP

-3.81x

EVMN

-1.33x

Growth & revenue

Revenue Growth TTM

CAMP

40.3%

Forward Revenue Growth

EVMN

881.5%

CAMP

-10.8%

Profitability & performance

Gross Margin

CAMP

35.8%

EVMN

0.0%

ROE

EVMN

-4676.0%

CAMP

-19474.0%

FCF Yield %

CAMP

-14.7%

EVMN

-55.4%

52-Week Performance

CAMP

6.5%

EVMN

-69.1%

Detailed metrics comparison

CAMP

CAMP4 Therapeutics Corp

EVMN

Evommune Inc

Market Cap

CAMP$196M

EVMN$225M

Enterprise Value

CAMP$109M

EVMN$166M

Price

CAMP$3.77

EVMN$6.25

P/E Ratio

CAMPN/A

EVMNN/A

P/S Ratio

CAMP46.44x

EVMN14.07x

EV/Sales

CAMP25.94x

EVMN10.38x

EV/EBITDA

CAMP0.00x

EVMN0.00x

P/B Ratio

CAMP8.12x

EVMN0.90x

P/FCF Ratio

CAMPN/A

EVMNN/A

EV/FCF

CAMP-3.81x

EVMN-1.33x

PEG Ratio

CAMPN/A

EVMNN/A

Forward P/E (NTM)

CAMPN/A

EVMNN/A

Forward P/S (NTM)

CAMP19.59x

EVMNN/A

Revenue (TTM)

CAMP$4M

EVMN$16M

Revenue Growth (YoY)

CAMP40.3%

EVMNN/A

Forward Rev Growth

CAMP-10.8%

EVMN881.5%

Gross Margin (TTM)

CAMP35.8%

EVMN0.0%

Operating Margin (TTM)

CAMP0.0%

EVMN0.0%

EBITDA Margin (TTM)

CAMP-1199.3%

EVMN-1097.9%

Net Margin (TTM)

CAMP-2543.7%

EVMN-943.2%

FCF Margin (TTM)

CAMP-681.2%

EVMN-779.8%

Net Income (TTM)

CAMP$-107M

EVMN$-151M

FCF (TTM)

CAMP$-29M

EVMN$-125M

EPS (TTM)

CAMP-$1.85

EVMN-$4.18

ROE (TTM)

CAMP-19474.0%

EVMN-4676.0%

ROA (TTM)

CAMP-10642.0%

EVMN-4337.0%

ROIC (TTM)

CAMP-19457.0%

EVMN-4661.0%

Cash

CAMP$86M

EVMN$60M

Debt

CAMP$0

EVMN$952K

Net Cash/Debt

CAMP$86M

EVMN$59M

Current Ratio (TTM)

CAMP4.70x

EVMN11.68x

Quick Ratio (TTM)

CAMP4.69x

EVMN11.48x

Debt/Equity (TTM)

CAMP0.00x

EVMN0.00x

Debt/Assets (TTM)

CAMP0.0%

EVMN0.0%

Interest Coverage (TTM)

CAMPN/A

EVMNN/A

Net Debt/EBITDA (TTM)

CAMP0.00x

EVMN0.00x

Beta

CAMP-24.51

EVMN0.62

52W Performance

CAMP6.5%

EVMN-69.1%

YTD Performance

CAMP-37.2%

EVMN-63.9%

% from 52W High

CAMP-51.4%

EVMN-81.2%

% from 52W Low

CAMP31.8%

EVMN3.8%

Asset Turnover (TTM)

CAMP0.79x

EVMN0.00x

FCF Yield (TTM)

CAMP-14.7%

EVMN-55.4%

Earnings Yield (TTM)

CAMP-54.8%

EVMN-67.0%

Dividend Yield (TTM)

CAMPN/A

EVMNN/A

Rule of 40

CAMP-640.9

EVMN-779.8

EV/GP/RG

CAMP0.53

EVMNN/A

Ticker research

View CAMP research View EVMN research

Metric	CAMP CAMP4 Therapeutics Corp	EVMN Evommune Inc
Market & Valuation
Market Cap	$196M	$225M
Enterprise Value	$109M	$166M
Price	$3.77	$6.25
P/E Ratio	N/A	N/A
P/S Ratio	46.44x	14.07x
EV/Sales	25.94x	10.38x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.12x	0.90x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.81x	-1.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	19.59x	N/A
Revenue & Growth
Revenue (TTM)	$4M	$16M
Revenue Growth (YoY)	40.3%	N/A
Forward Rev Growth	-10.8%	881.5%
Profitability
Gross Margin (TTM)	35.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1199.3%	-1097.9%
Net Margin (TTM)	-2543.7%	-943.2%
FCF Margin (TTM)	-681.2%	-779.8%
Net Income (TTM)	$-107M	$-151M
FCF (TTM)	$-29M	$-125M
EPS (TTM)	-$1.85	-$4.18
ROE (TTM)	-19474.0%	-4676.0%
ROA (TTM)	-10642.0%	-4337.0%
ROIC (TTM)	-19457.0%	-4661.0%
Financial Health
Cash	$86M	$60M
Debt	$0	$952K
Net Cash/Debt	$86M	$59M
Current Ratio (TTM)	4.70x	11.68x
Quick Ratio (TTM)	4.69x	11.48x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-24.51	0.62
52W Performance	6.5%	-69.1%
YTD Performance	-37.2%	-63.9%
% from 52W High	-51.4%	-81.2%
% from 52W Low	31.8%	3.8%
Efficiency & Yields
Asset Turnover (TTM)	0.79x	0.00x
FCF Yield (TTM)	-14.7%	-55.4%
Earnings Yield (TTM)	-54.8%	-67.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-640.9	-779.8
EV/GP/RG	0.53	N/A
Ticker research	View CAMP research	View EVMN research